These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 7976233)
41. [Sodium valproate versus propranolol in the prophylactic treatment of migraine]. Kozubski W; Prusiński A Neurol Neurochir Pol; 1995; 29(6):937-47. PubMed ID: 8714731 [TBL] [Abstract][Full Text] [Related]
42. Propranolol vs flunarizine vs flunarizine plus propranolol in migraine without aura prophylaxis. A double-blind trial. Bordini CA; Arruda MA; Ciciarelli MC; Speciali JG Arq Neuropsiquiatr; 1997 Sep; 55(3B):536-41. PubMed ID: 9629401 [TBL] [Abstract][Full Text] [Related]
43. [The treatment of juvenile migraine using flunarizine or propranolol]. Lütschg J; Vassella F Schweiz Med Wochenschr; 1990 Nov; 120(46):1731-6. PubMed ID: 2251492 [TBL] [Abstract][Full Text] [Related]
44. [Tolfenamic acid versus paracetamol in migraine attacks. A double-blind study in general practice]. Nørrelund N; Christiansen LV; Plantener S Ugeskr Laeger; 1989 Sep; 151(38):2436-8. PubMed ID: 2678652 [TBL] [Abstract][Full Text] [Related]
45. Treatment of comorbid migraine and temporomandibular disorders: a factorial, double-blind, randomized, placebo-controlled study. Goncalves DA; Camparis CM; Speciali JG; Castanharo SM; Ujikawa LT; Lipton RB; Bigal ME J Orofac Pain; 2013; 27(4):325-35. PubMed ID: 24171182 [TBL] [Abstract][Full Text] [Related]
46. Efficacy and safety of exogenous ketone bodies for preventive treatment of migraine: A study protocol for a single-centred, randomised, placebo-controlled, double-blind crossover trial. Gross E; Putananickal N; Orsini AL; Schmidt S; Vogt DR; Cichon S; Sandor P; Fischer D Trials; 2019 Jan; 20(1):61. PubMed ID: 30654835 [TBL] [Abstract][Full Text] [Related]
47. A double-blind randomized controlled trial of low doses of propranolol, nortriptyline, and the combination of propranolol and nortriptyline for the preventive treatment of migraine. Domingues RB; Silva AL; Domingues SA; Aquino CC; Kuster GW Arq Neuropsiquiatr; 2009 Dec; 67(4):973-7. PubMed ID: 20069203 [TBL] [Abstract][Full Text] [Related]
48. Propranolol and femoxetine, a HT-uptake inhibitor, in migraine prophylaxis. A double-blind crossover study. Andersson PG; Petersen EN Acta Neurol Scand; 1981 Oct; 64(4):280-8. PubMed ID: 7032183 [TBL] [Abstract][Full Text] [Related]
49. Safety and tolerability of short-term preventive frovatriptan: a combined analysis. MacGregor EA; Brandes JL; Silberstein S; Jeka S; Czapinski P; Shaw B; Pawsey S Headache; 2009 Oct; 49(9):1298-314. PubMed ID: 19788471 [TBL] [Abstract][Full Text] [Related]
50. A double blind controlled study of propranolol and cyproheptadine in migraine prophylaxis. Rao BS; Das DG; Taraknath VR; Sarma Y Neurol India; 2000 Sep; 48(3):223-6. PubMed ID: 11025624 [TBL] [Abstract][Full Text] [Related]
51. Tolfenamic acid and mefenamic acid in the treatment of primary dysmenorrhoea. Delgado J; Simonin G; Servier C; García R; Yoma J Pharmacol Toxicol; 1994; 75 Suppl 2():89-91. PubMed ID: 7816793 [TBL] [Abstract][Full Text] [Related]
53. Femoxetine - a new 5-HT uptake inhibitor - and propranolol in the prophylactic treatment of migraine. Kangasniemi PJ; Nyrke T; Lang AH; Petersen E Acta Neurol Scand; 1983 Oct; 68(4):262-7. PubMed ID: 6606930 [TBL] [Abstract][Full Text] [Related]
54. Comparing the Effects of Atorvastatin With Sodium Valproate (Divalproex) on Frequency and Intensity of Frequent Migraine Headaches: A Double-blind Randomized Controlled Study. Hesami O; Sistanizad M; Asadollahzade E; Johari MS; Beladi-Moghadam N; Mazhabdar-Ghashghai H Clin Neuropharmacol; 2018; 41(3):94-97. PubMed ID: 29746282 [TBL] [Abstract][Full Text] [Related]
55. Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. Tronvik E; Stovner LJ; Helde G; Sand T; Bovim G JAMA; 2003 Jan; 289(1):65-9. PubMed ID: 12503978 [TBL] [Abstract][Full Text] [Related]